Prices delayed by at least 15 minutes | Print
Renalytix PLC (RENX)
ORD 0.25POpen
8.00p
Previous close
8.00p
Trade high
8.40p
Volume
73,993
Year high
30.00p
Year low
6.50p
Dividend yield
–
Market capitalisation
£27.82 mn
P/E ratio
–
ISIN
GB00BYWL4Y04
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease diagnosis and prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 25/04/2025 | 04:22:57 | 8.4 | 10,000 | 840.00 |
| 25/04/2025 | 04:22:35 | 8.4 | 10,000 | 840.00 |
| 25/04/2025 | 04:12:25 | 7.5 | 2,500 | 187.50 |
| 25/04/2025 | 02:29:46 | 7.65 | 10,000 | 765.00 |
| 25/04/2025 | 11:47:38 | 7.64 | 16,000 | 1,222.40 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.